Author

Cristiana Forni

Observed names: C Forni, C. Forni, Cristiana FORNI, Forni, Cristiana

Institution: Istituto Ortopedico Rizzoli

Observed institutions: University of Verona, University of Modena and Reggio Emilia, Dalhousie University, University of Padua, Lund University, University of Milan, Mario Negri Institute for Pharmacological Research, Cancer Research UK, CTO Hospital, Agostino Gemelli University Polyclinic, Luigi Sacco Hospital, Azienda Ospedaliera Universitaria Integrata Verona, Heartlands Hospital, Meyer Children's Hospital, PharmaMar (Spain), Istituto Ortopedico Rizzoli, Cancer Research UK Clinical Trials Unit, Society of Surgical Oncology, Azienda Ospedale - Università Padova, Ospedale Santa Maria della Misericordia di Rovigo, Istituti di Ricovero e Cura a Carattere Scientifico, Fondazione IRCCS Istituto Nazionale dei Tumori, Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo, University of Turin, University of Birmingham, University of Bologna

ORCID: 0000-0003-4611-9261

Observed ORCID: 0000-0003-4611-9261

OpenAlex ID: A5015465249

Long-Term Outcome for Patients With Nonmetastatic Osteosarcoma of the Extremity Treated at the Istituto Ortopedico Rizzoli According to the Istituto Ortopedico Rizzoli/Osteosarcoma-2 Protocol: An Updated Report

2000 · Gaetano Bacci, Stefano Ferrari, et al. · Journal of Clinical Oncology · 438

Prognostic Factors in Nonmetastatic Ewing’s Sarcoma of Bone Treated With Adjuvant Chemotherapy: Analysis of 359 Patients at the Istituto Ortopedico Rizzoli

2000 · Gaetano Bacci, Stefano Ferrari, et al. · Journal of Clinical Oncology · 327

Neoadjuvant chemotherapy for high‐grade central osteosarcoma of the extremity

2003 · Gaetano Bacci, Franco Bertoni, et al. · Cancer · 254

PDF

One-year mortality after hip fracture surgery and prognostic factors: a prospective cohort study

2019 · Mattia Morri, Elisa Ambrosi, et al. · Scientific Reports · 223

PDF

High grade osteosarcoma of the extremities with lung metastases at presentation: Treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions

2008 · Gaetano Bacci, Michele Rocca, et al. · Journal of Surgical Oncology · 203

Osteosarcoma of the limb

2002 · G. Bacci, S. Ferrari, et al. · Journal of Bone and Joint Surgery - British Volume · 193

PDF

Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide

2003 · G. Bacci, A. Briccoli, et al. · Annals of Oncology · 187

PDF

Neoadjuvant chemotherapy for osteosarcoma of the extremity

2001 · G Bacci, A Briccoli, et al. · European Journal of Cancer · 174

Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992

2003 · G. Bacci, C. Forni, et al. · European Journal of Cancer · 164

A comment on “Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders”

2003 · G. Bacci, A. Longhi, et al. · European Journal of Cancer · 155

Local recurrence and local control of non‐metastatic osteosarcoma of the extremities: A 27‐year experience in a single institution

2007 · Gaetano Bacci, Cristiana Forni, et al. · Journal of Surgical Oncology · 143

Predictive factors for local recurrence in osteosarcoma 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy

1998 · Gaetano Bacci, Stefano Ferrari, et al. · Acta Orthopaedica Scandinavica · 141

PDF

Therapy and survival after recurrence of Ewing’s tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997

2003 · G. Bacci, S. Ferrari, et al. · Annals of Oncology · 124

PDF

Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy

2001 · G Bacci, S Ferrari, et al. · European Journal of Cancer · 119

Nonmetastatic osteosarcoma of the extremity with pathologic fracture at presentationLocal and systemic control by amputation or limb salvage after preoperative chemotherapy

2003 · Gaetano Bacci, Stefano Ferrari, et al. · Acta Orthopaedica Scandinavica · 111

PDF

Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions.

1997 · G Bacci, M Mercuri, et al. · PubMed · 109

High Dose Ifosfamide in Combination with High Dose Methotrexate, Adriamycin and Cisplatin in the Neoadjuvant Treatment of Extremity Osteosarcoma: Preliminary Results of an Italian Sarcoma Group/Scandinavian Sarcoma Group Pilot Study

2002 · G. Bacci, S. Ferrari, et al. · Journal of Chemotherapy · 100

Osteogenic sarcoma of the extremity with detectable lung metastases at presentation

1997 · Gaetano Bacci, Mario Mercuri, et al. · Cancer · 100

PDF

Neoadjuvant chemotherapy for Ewing's sarcoma of bone

1998 · Gaetano Bacci, Piero Picci, et al. · Cancer · 81

PDF

The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-κB target genes by interaction with NFKBIZ

2008 · M Göransson, M K Andersson, et al. · Oncogene · 75

Neoadjuvant Chemotherapy for Osteosarcoma of the Extremity

2003 · Gaetano Bacci, Cristiana Forni, et al. · Journal of Pediatric Hematology/Oncology · 70

Adjuvant and neoadjuvant chemotherapy for Ewing sarcoma family tumors in patients aged between 40 and 60

2007 · Gaetano Bacci, Alba Balladelli, et al. · Cancer · 69

Predictive Factors for Pressure Ulcers in an Older Adult Population Hospitalized for Hip Fractures: A Prognostic Cohort Study

2017 · Paolo Chiari, Cristiana Forni, et al. · PLoS ONE · 68

Neoadjuvant chemotherapy for Ewing's tumour of bone: recent experience at the Rizzoli Orthopaedic Institute

2002 · G. Bacci, M. Mercuri, et al. · European Journal of Cancer · 68

Prognostic significance of serum alkaline phosphatase in osteosarcoma of the extremity treated with neoadjuvant chemotherapy: Recent experience at Rizzoli Institute